We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$229M
Cap. Flow
-$115M
Cap. Flow %
-7.69%
Top 10 Hldgs %
22.33%
Holding
2,451
New
741
Increased
498
Reduced
386
Closed
708

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$48.3M
2
COL
Rockwell Collins
COL
+$34.6M
3
DELL icon
Dell
DELL
+$33.7M
4
CA
CA, Inc.
CA
+$33.7M
5
NXPI icon
NXP Semiconductors
NXPI
+$23.7M

Sector Composition

Rank Sector Weight
1 Technology 11.52%
2 Communication Services 10.15%
3 Healthcare 7.28%
4 Consumer Discretionary 5.72%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBF icon
1226
Ennis
EBF
$564M
$20K ﹤0.01%
1,027
+161
+19% +$3.09K
KSS icon
1227
CALL
Kohl's
KSS
$2.19B
$20K ﹤0.01%
+300
New +$21.1K
TPR icon
1228
Tapestry
TPR
$32.8B
$20K ﹤0.01%
580
-4,149
-88% -$167K
MDR
1229
CALL
DELISTED
McDermott International
MDR
$20K ﹤0.01%
+3,100
New +$32.7K
CRI icon
1230
Carter's
CRI
$1.47B
$19K ﹤0.01%
+235
New +$21.4K
FBIN icon
1231
CALL
Fortune Brands Innovations
FBIN
$6.06B
$19K ﹤0.01%
+585
New +$22.1K
HLF icon
1232
Herbalife
HLF
$1.29B
$19K ﹤0.01%
322
-456
-59% -$25.2K
UAA icon
1233
Under Armour
UAA
$2.6B
$19K ﹤0.01%
+1,067
New +$21.9K
CMBT
1234
CMB.TECH NV
CMBT
$4.73B
$19K ﹤0.01%
2,682
-77,963
-97% -$668K
NLSN
1235
CALL
DELISTED
Nielsen Holdings plc
NLSN
$19K ﹤0.01%
800
AMC icon
1236
CALL
AMC Entertainment Holdings
AMC
$2.31B
$18K ﹤0.01%
+150
New +$24.6K
FNKO icon
1237
CALL
Funko
FNKO
$328M
$18K ﹤0.01%
+1,400
New +$23.4K
INGR icon
1238
Ingredion
INGR
$6.58B
$18K ﹤0.01%
+200
New +$20K
MGRC icon
1239
McGrath RentCorp
MGRC
$2.92B
$18K ﹤0.01%
356
+100
+39% +$5.14K
NBR icon
1240
CALL
Nabors Industries
NBR
$1.21B
$18K ﹤0.01%
+180
New +$39.6K
STNG icon
1241
Scorpio Tankers
STNG
$3.81B
$18K ﹤0.01%
1,000
-32,459
-97% -$604K
TTEC icon
1242
TTEC Holdings
TTEC
$124M
$18K ﹤0.01%
635
+603
+1,884% +$16K
SYNH
1243
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$18K ﹤0.01%
+464
New +$21.6K
CMTA
1244
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$18K ﹤0.01%
1,533
-721
-32% -$8.97K
REV
1245
PUT
DELISTED
Revlon, Inc.
REV
$18K ﹤0.01%
700
+400
+133% +$9.87K
FF icon
1246
Future Fuel
FF
$223M
$17K ﹤0.01%
1,094
-1,155
-51% -$19.2K
MED icon
1247
Medifast
MED
$141M
$17K ﹤0.01%
136
-224
-62% -$38.3K
NBIX icon
1248
Neurocrine Biosciences
NBIX
$16.6B
$17K ﹤0.01%
239
-11,805
-98% -$1.13M
NUS icon
1249
Nu Skin
NUS
$267M
$17K ﹤0.01%
+277
New +$18.7K
RICK icon
1250
RCI Hospitality Holdings
RICK
$215M
$17K ﹤0.01%
762
+500
+191% +$12.5K

Similar funds

Prelude Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Prelude Capital Management held 2,451 positions worth $1.49B, down 13% from $1.72B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management withdrew a net $115M in Q4 2018, closing 708 positions and reducing 386 holdings. Its most notable exit was Aetna Inc, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 15% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Red Hat Inc worth $33.2M.

  • Prelude Capital Management's largest Q4 2018 buy was Red Hat Inc: 189,248 shares worth $33.2M.
  • Prelude Capital Management added most to Athenahealth, Inc. in Q4 2018, an estimated $16M increase.
  • Prelude Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $33.7M.
  • Prelude Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $48.3M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.49B portfolio in Q4 2018.
  • Prelude Capital Management opened 741 new positions and closed 708 in Q4 2018.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.